|
|
|
Lifestream Announces RxSchool's Launch of National Pharmacy Education Program; Continuing Education Program Focuses on Increasing Patient Adherence Through Home Monitoring
[Business Wire]
POST FALLS, Idaho--(BUSINESS WIRE)--July 27, 2004--Lifestream Technologies, Inc. (OTCBB:LFTC), the leading manufacturer of home cholesterol monitors and professional screening devices, today announced that RxSchool is releasing a new pharmacy continuing education program designed to provide pharmacists with a greater understanding of the role home cholesterol monitoring plays in helping patients manage their cholesterol levels and improve overall patient compliance.
Steve Croke, President of RxSchool, stated, "Those patients on cholesterol-lowering drugs rarely stay on them long enough to derive the cardiovascular benefits the therapy can provide. The science is clear that one effective method is for patients to get regular feedback from self monitoring. To educate the pharmacist on this science is key to making a change in adherence. This is one of our best CE programs yet, and we are very excited about being able to provide pharmacists with an opportunity to adopt new tools in their effort to control heart disease."
"With only 30% of patients remaining on statin drugs after the first year, the value of improving patient adherence is undeniable," said Christopher Maus, Lifestream's President and CEO. "Statin drugs, considered by many to be extremely important for Americans' cardiovascular health, is the largest drug sector, exceeding $17 billion a year. Monitoring cholesterol at home is a proven method for enhancing patient adherence. It is very important that pharmacists understand the nature and value of patient self monitoring."
"We are very pleased that RxSchool, one the nation's premier providers for continuing education, has elected to provide this educational campaign for cholesterol management," stated Ed Siemens, Lifestream's COO. "These efforts will provide pharmacists throughout the U.S. with additional knowledge to support their patients in managing cholesterol through home monitoring. The role of home monitoring in the continuum of care is growing in importance. We are pleased that pharmacists, 120,000 strong, will have such a valuable educational resource."
About RxSchool.com
A division of Pharmacy Choice, Inc., RxSchool is an e-learning web portal and software solutions company that provides a comprehensive suite of educational courses and training tools for the health care industry. The RxSchool website is utilized by tens of thousands of pharmacists, pharmacy technicians, physicians and nurses who practice in hospital, retail, managed care, long-term care, private practice and various other health care settings. As a leader in educational solutions for the industry, RxSchool is supported by pharmaceutical industry sponsors and endorsed by industry associations, employers and educational institutions. For more information about RxSchool or Pharmacy Choice, please visit their respective web sites at www.rxschool.com or www.pharmacychoice.com
About Lifestream Technologies
The Company developed and currently markets a line of cholesterol monitors to consumers and healthcare professionals that provide test results in three minutes.
The Company's product line aids the health-conscious consumer in monitoring their risk of heart disease. By regularly testing cholesterol at home, individuals can monitor the benefits of their diet, exercise and/or drug therapy programs. Monitoring these benefits can support the physician and the individual's efforts to improve compliance. Lifestream's products also integrate a smart card reader, further supporting compliance by storing test results on an individual's personal health card for future retrieval, trend analysis and assessment.
Lifestream's monitors are affordable, hand-held devices that provide users with accurate results in less than three minutes. The product line has been designed to accommodate The Data Concern™ Personal Health Card®, allowing multiple users the ability to store their personal results. Lifestream's products are now available in pharmacy and retail outlets nationwide. To find retailers that carry Lifestream's products, go to "Store Locator" on www.knowitforlife.com or contact Customer Care at 888-954-LIFE. For Company information, visit www.lifestreamtech.com.
This news release includes certain forward-looking statements within the meaning of the safe harbor protections of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such forward-looking statements include, but are not limited to, statements regarding our current business plans, strategies and objectives that involve risks and uncertainties and, in particular, statements referring to our expectations for increased market penetration and improved gross margins from our recently introduced second-generation consumer monitors and statements regarding our expectations that we can obtain necessary additional financing and investment.
These forward-looking statements involve risks and uncertainties that could cause actual results to differ from anticipated results.
The forward-looking statements are based on our current expectations and what we believe are reasonable assumptions given our knowledge of the relevant markets; however, our actual performance, results and achievements could differ materially from those expressed in, or implied by, these forward-looking statements.
Factors, within and beyond our control, that could cause or contribute to such differences include, among others, the following: the success of our capital-raising and cost-cutting efforts, developing and marketing relatively new medical diagnostic devices, including technological advancements and innovations; consumer receptivity and preferences; availability, affordability and coverage terms of private and public medical insurance; political and regulatory environments and general economic and business conditions; the effects of our competition; the success of our operating, marketing and growth initiatives; development and operating costs; the amount and effectiveness of our advertising and promotional efforts; brand awareness; the existence of adverse publicity; changes in business strategies or development plans; quality and experience of our management; availability, terms and deployment of capital; labor and employee benefit costs; as well as those factors discussed in our most recent Registration Statement on Form SB-2 filed June 10, 2004, and in "Item 1 -- Our Business," "Item 6 -- Our Management's Discussion and Analysis," particularly the discussion under "Risk Factors -- Substantial Doubt as to our Ability to Continue as a Going Concern" and elsewhere in our most recent Annual Report on Form 10-KSB for our fiscal year ended June 30, 2003, both filed with the United States Securities and Exchange Commission. Readers are urged to carefully review and consider the various disclosures made by us in this report, in the aforementioned Form SB-2 and Form 10-KSB, and those detailed from time to time in our other reports and filings with the United States Securities and Exchange Commission that attempt to advise interested parties of the risks and factors that are likely to affect our business.
Copyright © 2004 Business Wire
|
|
|
|
|
|
